87/100BGilead Sciences reports its Q4 FY2026 results on 9 February 2027, after the market closes. Analysts expect earnings per share of 1.39 USD and revenue of 8.28B USD.
In Q3 FY2026, reported on 29 October 2026, Gilead Sciences earned 2.55 USD a share against the 2.19 USD analysts expected (+16.4%), on revenue of 8.30B USD against 7.81B USD (+6.3%).
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2.17 | — | — | +7.12% | 7.49B | — | — | +7.60% | — | |
| Q4 FY2026 | 1.39 | — | — | -25.27% | 8.28B | — | — | +4.52% | — | |
| Q3 FY2026 | 2.19 | 2.55 | +16.44% | +3.24% | 7.81B | 8.30B | +6.34% | +6.83% | +3.1% | |
| Q2 FY2026 | -7.25 | -6.75 | +6.90% | -435.82% | 7.40B | 7.80B | +5.47% | +10.20% | -2.5% | |
| Q1 FY2026 | 1.91 | 2.03 | +6.28% | +12.15% | 6.91B | 6.96B | +0.67% | +4.39% | -2.2% | |
| Q4 FY2025 | 1.81 | 1.86 | +2.76% | -2.11% | 7.69B | 7.93B | +3.05% | +4.70% | +5.8% | |
| Q3 FY2025 | 2.13 | 2.47 | +15.96% | +22.28% | 7.45B | 7.77B | +4.35% | +2.97% | +1.1% | |
| Q2 FY2025 | 1.96 | 2.01 | +2.55% | 0.00% | 6.98B | 7.08B | +1.43% | +1.90% | +8.2% | |
| Q1 FY2025 | 1.78 | 1.81 | +1.69% | — | 6.81B | 6.67B | -2.11% | -0.28% | -2.8% | |
| Q4 FY2024 | 1.74 | 1.90 | +9.20% | +10.47% | 7.15B | 7.57B | +5.82% | +6.38% | +7.5% | |
| Q3 FY2024 | 1.53 | 2.02 | +32.03% | -11.79% | 7.02B | 7.55B | +7.55% | +7.02% | +6.8% | |
| Q2 FY2024 | 1.61 | 2.01 | +24.84% | +50.00% | 6.70B | 6.95B | +3.68% | +5.30% | -2.5% | |
| Q1 FY2024 | -1.49 | -1.32 | +11.41% | -196.35% | 6.36B | 6.69B | +5.17% | +5.26% | +0.2% | |
| Q4 FY2023 | 1.76 | 1.72 | -2.27% | +2.99% | 7.10B | 7.12B | +0.20% | -3.71% | -4.2% | |
| Q3 FY2023 | 1.91 | 2.29 | +19.90% | +20.53% | 6.42B | 7.05B | +9.86% | +0.11% | -3.3% | |
| Q2 FY2023 | 1.60 | 1.34 | -16.25% | -15.19% | 6.46B | 6.60B | +2.19% | +5.42% | +4.2% | |
| Q1 FY2023 | 1.63 | 1.37 | -15.95% | -35.38% | 6.46B | 6.35B | -1.60% | -3.61% | -1.6% | |
| Q4 FY2022 | 1.50 | 1.67 | +11.33% | +142.03% | 6.64B | 7.39B | +11.36% | +2.00% | +3.9% | |
| Q3 FY2022 | 1.44 | 1.90 | +31.94% | -28.30% | 6.13B | 7.04B | +14.87% | -5.11% | +12.9% | |
| Q2 FY2022 | 1.51 | 1.58 | +4.64% | -15.51% | 5.86B | 6.26B | +6.80% | +0.69% | +4.6% | |
| Q1 FY2022 | 1.77 | 2.12 | +19.77% | +1.92% | 6.29B | 6.59B | +4.85% | +2.60% | -3.6% | |
| Q4 FY2021 | 1.53 | 0.69 | -54.90% | -68.49% | 6.61B | 7.24B | +9.51% | -2.39% | -3.8% | |
| Q3 FY2021 | 1.75 | 2.65 | +51.43% | +25.59% | 6.15B | 7.42B | +20.58% | +12.83% | -3.6% | |
| Q2 FY2021 | 1.76 | 1.87 | +6.25% | +68.47% | 6.22B | 6.22B | 0.00% | +20.88% | -2.2% | |
| Q1 FY2021 | 2.06 | 2.08 | +0.97% | +23.81% | 6.68B | 6.42B | -3.90% | +15.77% | -0.6% | |
| Q4 FY2020 | 2.15 | 2.19 | +1.86% | +68.46% | 6.73B | 7.42B | +10.24% | +26.23% | +3.9% | |
| Q3 FY2020 | 1.83 | 2.11 | +15.30% | +20.57% | 5.92B | 6.58B | +11.05% | +17.36% | -0.4% | |
| Q2 FY2020 | 1.46 | 1.11 | -23.97% | -39.01% | 6.72B | 5.14B | -23.45% | -9.53% | -3.9% | |
| Q1 FY2020 | 1.58 | 1.68 | +6.33% | -4.55% | 5.22B | 5.55B | +6.33% | +5.06% | -4.5% | |
| Q4 FY2019 | 1.68 | 1.30 | -22.62% | -9.72% | 7.55B | 5.88B | -22.16% | +1.45% | -2.3% | |
| Q3 FY2019 | 1.76 | 1.75 | -0.57% | -4.89% | 5.57B | 5.60B | +0.57% | +0.14% | -4.0% | |
| Q2 FY2019 | 1.72 | 1.82 | +5.81% | -4.71% | 5.37B | 5.69B | +5.81% | +0.66% | -2.4% | |
| Q1 FY2019 | 1.61 | 1.76 | +9.32% | +18.92% | 4.83B | 5.28B | +9.32% | +3.79% | +2.8% | |
| Q4 FY2018 | 1.70 | 1.44 | -15.29% | -19.10% | 6.84B | 5.80B | -15.29% | -2.59% | -3.4% | |
| Q3 FY2018 | 1.63 | 1.84 | +12.88% | -18.94% | 4.96B | 5.60B | +12.88% | -14.07% | +1.6% | |
| Q2 FY2018 | 1.55 | 1.91 | +23.23% | -25.39% | 4.61B | 5.65B | +22.44% | -20.91% | -1.0% | |
| Q1 FY2018 | 1.67 | 1.48 | -11.38% | -33.63% | 5.74B | 5.09B | -11.38% | -21.78% | -8.1% | |
| Q4 FY2017 | 1.70 | 1.78 | +4.71% | -34.07% | 5.58B | 5.95B | +6.59% | -18.73% | +3.3% | |
| Q3 FY2017 | 2.13 | 2.27 | +6.57% | -17.45% | 6.11B | 6.51B | +6.57% | -13.17% | -1.0% | |
| Q2 FY2017 | 2.15 | 2.56 | +19.07% | -16.88% | 6.00B | 7.14B | +19.07% | -8.17% | +1.2% | |
| Q1 FY2017 | 2.28 | 2.23 | -2.19% | -26.40% | 6.65B | 6.51B | -2.19% | -16.54% | -2.0% | |
| Q4 FY2016 | 2.61 | 2.70 | +3.45% | -18.67% | 7.08B | 7.32B | +3.45% | -13.94% | -8.6% | |
| Q3 FY2016 | 2.86 | 2.75 | -3.85% | -14.60% | 7.80B | 7.50B | -3.85% | -9.58% | -2.1% | |
| Q2 FY2016 | 3.02 | 3.08 | +1.99% | -2.22% | 7.62B | 7.78B | +1.99% | -5.68% | -8.5% | |
| Q1 FY2016 | 3.15 | 3.03 | -3.81% | +3.06% | 8.10B | 7.79B | -3.81% | +2.63% | -9.1% | |
| Q4 FY2015 | 3.00 | 3.32 | +10.67% | +36.63% | 7.69B | 8.51B | +10.67% | +16.30% | +4.4% | |
| Q3 FY2015 | 2.87 | 3.22 | +12.20% | +57.07% | 7.39B | 8.30B | +12.20% | +37.29% | -2.6% | |
| Q2 FY2015 | 2.71 | 3.15 | +16.24% | +33.47% | 7.09B | 8.24B | +16.24% | +26.15% | +2.3% | |
| Q1 FY2015 | 2.32 | 2.94 | +26.72% | +98.65% | 5.99B | 7.59B | +26.72% | +51.91% | +4.5% | |
| Q4 FY2014 | 2.22 | 2.43 | +9.46% | +341.82% | 6.68B | 7.31B | +9.45% | +134.44% | -8.2% | |
| Q3 FY2014 | 1.92 | 2.05 | +6.77% | +294.23% | 6.30B | 6.04B | -4.17% | +117.11% | -2.4% | |
| Q2 FY2014 | 1.79 | 2.36 | +31.84% | +372.00% | 4.96B | 6.53B | +31.84% | +136.14% | +0.2% | |
| Q1 FY2014 | 0.91 | 1.48 | +62.64% | +208.33% | 3.07B | 5.00B | +62.64% | +97.46% | +1.4% | |
| Q4 FY2013 | 0.50 | 0.55 | +10.00% | +10.00% | 2.84B | 3.12B | +10.00% | +20.54% | -4.7% | |
| Q3 FY2013 | 0.48 | 0.52 | +8.33% | +4.00% | 2.57B | 2.78B | +8.33% | +14.68% | +4.6% | |
| Q2 FY2013 | 0.50 | 0.50 | 0.00% | +100.00% | 2.77B | 2.77B | -0.00% | +15.06% | +2.8% | |
| Q1 FY2013 | 0.50 | 0.48 | -4.00% | +108.70% | 2.64B | 2.53B | -4.00% | +10.92% | +5.7% | |
| Q4 FY2012 | 0.48 | 0.50 | +4.17% | +2.04% | 2.48B | 2.59B | +4.17% | +17.63% | +2.4% | |
| Q3 FY2012 | 0.47 | 0.50 | +6.38% | -1.96% | 2.28B | 2.43B | +6.38% | +14.37% | +5.3% | |
| Q2 FY2012 | 0.48 | 0.25 | -47.92% | -50.00% | 2.31B | 2.41B | +4.17% | +12.54% | +7.4% | |
| Q1 FY2012 | 0.47 | 0.23 | -51.06% | -47.73% | 2.33B | 2.28B | -2.13% | +18.50% | -1.1% | |
| Q4 FY2011 | 0.52 | 0.49 | -5.77% | +2.08% | 2.34B | 2.20B | -5.77% | +10.09% | +10.9% | |
| Q3 FY2011 | 0.50 | 0.51 | +2.00% | +13.33% | 2.08B | 2.12B | +2.00% | +9.50% | +1.6% | |
| Q2 FY2011 | 0.50 | 0.50 | 0.00% | +16.28% | 2.14B | 2.14B | -0.00% | +10.90% | +1.9% | |
| Q1 FY2011 | 0.48 | 0.44 | -8.33% | -12.00% | 2.10B | 1.93B | -8.33% | -7.66% | -4.2% | |
| Q4 FY2010 | 0.47 | 0.48 | +2.13% | +2.13% | 1.96B | 2.00B | +2.13% | -1.66% | +3.9% | |
| Q3 FY2010 | 0.44 | 0.45 | +2.27% | +15.38% | 1.89B | 1.94B | +2.27% | +7.56% | +4.6% | |
| Q2 FY2010 | 0.43 | 0.43 | 0.00% | +22.86% | 1.93B | 1.93B | +0.00% | +17.00% | -0.3% | |
| Q1 FY2010 | 0.48 | 0.50 | +4.17% | +51.52% | 2.00B | 2.09B | +4.16% | +36.29% | -9.6% | |
| Q4 FY2009 | 0.42 | 0.47 | +11.90% | +56.67% | 1.79B | 2.03B | +13.51% | +42.30% | +7.0% | |
| Q3 FY2009 | 0.34 | 0.39 | +14.71% | +50.00% | 1.57B | 1.80B | +14.71% | +31.37% | -1.7% | |
| Q2 FY2009 | 0.31 | 0.35 | +12.90% | +52.17% | 1.46B | 1.65B | +12.90% | +28.87% | -1.4% | |
| Q1 FY2009 | 0.30 | 0.33 | +10.00% | +26.92% | 1.39B | 1.53B | +10.00% | +21.64% | +5.7% | |
| Q4 FY2008 | 0.27 | 0.30 | +11.11% | +42.86% | 1.29B | 1.43B | +11.11% | +30.46% | +4.8% | |
| Q3 FY2008 | 0.25 | 0.26 | +4.00% | +23.81% | 1.32B | 1.37B | +4.00% | +29.51% | +4.0% | |
| Q2 FY2008 | 0.24 | 0.23 | -4.17% | +9.52% | 1.33B | 1.28B | -4.16% | +21.95% | -10.6% | |
| Q1 FY2008 | 0.24 | 0.26 | +8.33% | +23.81% | 1.16B | 1.26B | +8.33% | +22.34% | -3.6% | |
| Q4 FY2007 | 0.20 | 0.21 | +5.00% | +5.00% | 1.04B | 1.09B | +5.00% | +21.74% | +1.7% | |
| Q3 FY2007 | 0.20 | 0.21 | +5.00% | +31.25% | 1.01B | 1.06B | +5.00% | +41.41% | -3.4% | |
| Q2 FY2007 | 0.20 | 0.21 | +5.00% | +50.00% | 998.19M | 1.05B | +5.00% | +52.94% | -4.1% | |
| Q1 FY2007 | 0.20 | 0.21 | +5.00% | +50.00% | 979.43M | 1.03B | +5.00% | +48.43% | +4.2% | |
| Q4 FY2006 | 0.17 | 0.20 | +17.65% | +42.86% | 764.32M | 899.23M | +17.65% | +47.59% | +11.2% | |
| Q3 FY2006 | 0.14 | 0.16 | +14.29% | +60.00% | 655.11M | 748.73M | +14.29% | +51.73% | +0.9% | |
| Q2 FY2006 | 0.13 | 0.14 | +7.69% | +40.00% | 636.35M | 685.30M | +7.69% | +38.37% | +0.6% | |
| Q1 FY2006 | 0.13 | 0.14 | +7.69% | +55.56% | 643.41M | 692.88M | +7.69% | +60.98% | +5.3% | |
| Q4 FY2005 | 0.13 | 0.14 | +7.69% | +133.33% | 562.40M | 609.27M | +8.33% | +64.85% | +5.2% | |
| Q3 FY2005 | 0.09 | 0.10 | +11.11% | +66.67% | 444.15M | 493.45M | +11.10% | +51.28% | -4.6% | |
| Q2 FY2005 | 0.09 | 0.10 | +11.11% | +66.67% | 445.77M | 495.27M | +11.10% | +54.91% | 0.0% | |
| Q1 FY2005 | 0.07 | 0.09 | +28.57% | +50.00% | 334.76M | 430.41M | +28.58% | +39.24% | +2.5% | |
| Q4 FY2004 | 0.06 | 0.06 | 0.00% | +20.00% | 369.59M | 369.59M | 0.00% | +40.25% | -0.2% | |
| Q3 FY2004 | 0.05 | 0.06 | +20.00% | +50.00% | 271.83M | 326.19M | +20.00% | +62.79% | -9.4% | |
| Q2 FY2004 | 0.04 | 0.06 | +38.12% | 0.00% | 213.13M | 319.72M | +50.01% | +33.85% | +8.6% | |
| Q1 FY2004 | 0.04 | 0.06 | +34.08% | +100.00% | 206.07M | 309.13M | +50.01% | +87.23% | +1.6% | |
| Q4 FY2003 | 0.05 | 0.05 | 0.00% | +150.00% | 263.52M | 263.52M | 0.00% | +81.70% | -9.7% | |
| Q3 FY2003 | 0.05 | 0.04 | -19.90% | +100.00% | 200.40M | 200.37M | -0.01% | +49.55% | -12.5% | |
| Q2 FY2003 | 0.06 | 0.06 | 0.00% | +402.51% | 238.90M | 238.87M | -0.01% | +118.42% | -5.4% | |
| Q1 FY2003 | 0.02 | 0.03 | +55.12% | — | 110.07M | 165.11M | +50.00% | +110.55% | +2.3% | |
| Q4 FY2002 | 0.02 | 0.02 | +13.83% | -76.82% | 145.03M | 145.03M | 0.00% | +95.11% | -4.8% | |
| Q3 FY2002 | 0.01 | 0.02 | +159.40% | — | 67.00M | 133.98M | +99.98% | +163.15% | +5.1% | |
| Q2 FY2002 | 0.00 | 0.01 | +139.76% | — | 109.40M | 109.36M | -0.03% | +115.76% | -4.5% | |
| Q1 FY2002 | -0.00 | -0.00 | -65.33% | — | 123.51M | 78.42M | -36.51% | +35.58% | +6.4% | |
| Q4 FY2001 | 0.07 | 0.09 | +17.26% | — | 100.35M | 74.33M | -25.93% | +34.50% | +6.6% | |
| Q3 FY2001 | -0.02 | -0.02 | -23.15% | — | 50.90M | 50.92M | +0.03% | +12.92% | -1.6% | |
| Q2 FY2001 | -0.01 | -0.02 | -43.27% | — | 25.35M | 50.69M | +99.95% | +1.42% | -1.2% | |
| Q1 FY2001 | -0.01 | -0.01 | -31.66% | — | 78.08M | 57.84M | -25.93% | +27.89% | +9.2% | |
| Q4 FY2000 | -0.02 | -0.02 | -6.55% | — | 55.27M | 55.27M | 0.00% | +13.25% | -2.0% | |
| Q3 FY2000 | -0.01 | -0.01 | -46.13% | — | 45.20M | 45.09M | -0.25% | +17.42% | -9.5% | |
| Q2 FY2000 | -0.00 | -0.00 | -64.61% | — | 77.31M | 49.98M | -35.35% | +474.47% | +4.3% | |
| Q1 FY2000 | -0.00 | -0.00 | -52.06% | — | 64.86M | 45.22M | -30.28% | +822.90% | +24.3% | |
| Q4 FY1999 | -0.00 | -0.01 | -42.73% | — | 48.80M | 48.80M | 0.00% | +442.22% | -1.3% | |
| Q3 FY1999 | -0.02 | -0.02 | -24.70% | — | 38.40M | 38.40M | 0.00% | +1,180.00% | -2.5% | |
| Q2 FY1999 | -0.01 | -0.01 | -13.69% | — | 8.70M | 8.70M | 0.00% | +24.29% | +13.6% | |
| Q1 FY1999 | -0.02 | -0.02 | -6.27% | — | 4.90M | 4.90M | 0.00% | -63.97% | +6.7% | |
| Q4 FY1998 | -0.02 | -0.02 | -18.91% | — | 9.00M | 9.00M | 0.00% | -9.09% | +5.6% | |
| Q3 FY1998 | -0.02 | -0.02 | -8.99% | — | 3.00M | 3.00M | 0.00% | -38.78% | +6.7% | |
| Q2 FY1998 | -0.02 | -0.02 | -15.01% | -768.90% | 7.00M | 7.00M | 0.00% | -64.47% | +1.1% | |
| Q1 FY1998 | -0.01 | -0.01 | -51.21% | — | 18.36M | 13.60M | -25.93% | +147.27% | 0.0% | |
| Q4 FY1997 | -0.01 | -0.01 | -9.28% | — | 9.90M | 9.90M | 0.00% | +70.69% | -3.1% | |
| Q3 FY1997 | -0.01 | -0.01 | -3.88% | -219.94% | 4.90M | 4.90M | 0.00% | -80.16% | +4.9% | |
| Q2 FY1997 | — | 0.00 | — | — | — | 19.70M | — | +795.45% | +3.4% | |
| Q1 FY1997 | — | -0.01 | — | — | — | 5.50M | — | +587.50% | -1.7% | |
| Q4 FY1996 | -0.01 | -0.01 | -21.38% | — | 5.80M | 5.80M | 0.00% | — | 0.0% | |
| Q3 FY1996 | — | 0.01 | — | — | — | 24.70M | — | +2,145.45% | -6.3% | |
| Q2 FY1996 | — | -0.01 | — | — | — | 2.20M | — | +144.44% | -6.9% | |
| Q1 FY1996 | -0.01 | -0.01 | -21.37% | — | — | 800.00K | — | -11.11% | -4.7% | |
| Q3 FY1995 | — | -0.01 | — | — | — | 1.10M | — | -31.25% | +0.7% | |
| Q2 FY1995 | -0.01 | -0.01 | -22.62% | — | — | 900.00K | — | -18.18% | +0.7% | |
| Q1 FY1995 | -0.01 | -0.01 | -25.38% | — | — | 900.00K | — | -18.18% | 0.0% | |
| Q4 FY1994 | -0.01 | -0.01 | -17.32% | — | — | 1.30M | — | +18.18% | +5.6% | |
| Q3 FY1994 | — | -0.01 | — | — | — | 1.60M | — | +60.00% | -11.6% | |
| Q2 FY1994 | — | -0.01 | — | — | — | 1.10M | — | +10.00% | 0.0% | |
| Q1 FY1994 | -0.01 | -0.01 | -12.62% | — | — | 1.10M | — | +10.00% | -2.8% | |
| Q4 FY1993 | -0.01 | -0.01 | -25.84% | — | — | 1.10M | — | +10.00% | +2.0% | |
| Q3 FY1993 | -0.01 | -0.01 | -40.45% | — | — | 1.00M | — | — | +5.3% | |
| Q2 FY1993 | — | -0.01 | — | — | — | 1.00M | — | -9.09% | +3.6% | |
| Q1 FY1993 | — | -0.01 | — | — | — | 1.00M | — | — | -1.6% | |
| Q4 FY1992 | — | -0.01 | — | — | — | 1.00M | — | +100.00% | 0.0% | |
| Q4 FY1992 | — | -0.01 | — | — | — | 1.00M | — | +100.00% | -5.2% | |
| Q2 FY1992 | — | -0.00 | — | — | — | 1.10M | — | +450.00% | -2.0% | |
| Q4 FY1991 | — | -0.00 | — | — | — | 2.80M | — | +2,700.00% | -5.3% | |
| Q4 FY1991 | — | -0.00 | — | — | — | 500.00K | — | +400.00% | — | |
| Q3 FY1991 | — | -0.00 | — | — | — | 200.00K | — | +100.00% | — | |
| Q2 FY1991 | — | -0.00 | — | — | — | 200.00K | — | +100.00% | — | |
| Q4 FY1990 | — | -0.00 | — | — | — | 1.20M | — | — | — | |
| Q4 FY1990 | — | -0.00 | — | — | — | 100.00K | — | — | — | |
| Q3 FY1990 | — | -0.00 | — | — | — | 100.00K | — | — | — | |
| Q2 FY1990 | — | -0.00 | — | — | — | 100.00K | — | — | — |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 10.78 | — | — | +6.70% | 34.78B | — | — | +3.84% |
| FY2027 | 10.10 | — | — | — | 33.49B | — | — | +7.10% |
| FY2026 | -0.85 | — | — | -110.41% | 31.27B | — | — | +6.20% |
| FY2025 | 8.11 | 8.15 | +0.46% | +76.79% | 29.23B | 29.44B | +0.73% | +2.41% |
| FY2024 | 4.41 | 4.61 | +4.54% | -31.40% | 28.32B | 28.75B | +1.51% | +6.02% |
| FY2023 | 6.75 | 6.72 | -0.51% | -7.57% | 27.10B | 27.12B | +0.06% | -0.60% |
| FY2022 | 7.10 | 7.27 | +2.35% | -0.27% | 26.53B | 27.28B | +2.84% | -0.09% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
HIV medicines generate most of Gilead’s sales, so their performance is central to growth.
On average, analysts' EPS estimate was 11.0% off the result, either way, and their revenue estimate 3.8%, over the last 12 quarters.
See also:Forecast,EPS,Income statement
Source: Financial Modeling Prep
We value your privacy
We use cookies to enhance your experience and analyze site traffic. By continuing, you agree to our use of cookies. Privacy Policy
